STEAP1 and breast carcinoma: In breast cancer, STEAP1 and STEAP2 inhibit EMT by inhibiting EMT‐related genes and the PI3K/AKT/mTOR signaling pathway to impede cell proliferation, invasion, and metastasis [20, 21].